Previous Close | 0.9684 |
Open | 0.9900 |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.9900 - 1.0300 |
52 Week Range | 0.7670 - 2.2099 |
Volume | |
Avg. Volume | 16,625 |
Market Cap | 971.555M |
Beta (5Y Monthly) | -0.03 |
PE Ratio (TTM) | 7.77 |
EPS (TTM) | 0.1300 |
Earnings Date | N/A |
Forward Dividend & Yield | 0.08 (7.51%) |
Ex-Dividend Date | Jan 04, 2024 |
1y Target Est | N/A |
Famously made to last, the durability that led to its popularity may be the very thing keeping it from astronomic growth.
NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead. The London-based company's footwear became a symbol of youthful rebellion in the 1960s and has remained popular with a string of subcultures, from punk to goth since. But the business got tripped up with overexpansion and brand mismanagement in recent years. Shares in Dr. Martens PLC, known as Doc Martens, plunged Tuesday after the iconic brand forecast wholesale revenue in the U.S., its largest market, would decline
Shares of Dr. Martens (DOCS.L, DOCMF) are plunging after the boot maker warned its fiscal 2025 results will be hit by a double-digit decline in US wholesale revenue. The company also announced CEO Kenny Wilson will be stepping down at the end of the year. He will be replaced by Chief Brand Officer Ije Nwokorie. In the video above, Yahoo Finance's Seana Smith and Brad Smith discuss the announcements. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Stephanie Mikulich.